Evera™ S DR DDBC3D1 (UDI 00643169720411)Recalls & reported problems
Medtronic, Inc. · ICD-DR DDBC3D1 EVERA S US DF1 · Class 3 · Implant
All models of Evera S DR (8)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
Quick summary
This Medtronic Evera S implantable cardioverter-defibrillator detects and treats abnormal heart rhythms. Reports mainly describe inappropriate shocks, sensing problems, and lead or electrical issues, with some mentioning infection. There are 25 reports, including 1 death and 13 injuries; reports fell from 4 in the previous 12 months to 1 in the latest 12 months. The device has 1 open recall, started in May 2023, involving a rare possibility of reduced- or no-energy output during high-voltage therapy.
AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.
- Adverse event reports
- 25
- Deaths reported
- 1
- Injuries reported
- 13
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 25 adverse event reports that list this exact device (DI 00643169720411), received between Feb 25, 2019 and Dec 10, 2025 — classified as 1 death, 13 injuries, 11 malfunctions.
The most frequently reported specific device problem is “Device Sensing Problem” (7 reports).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Recalls naming this device
- May 10, 2023Open, Classified
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.
Z-1709-2023 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem7
- Device Sensing Problem7
- Inappropriate/Inadequate Shock/Stimulation7
- Electrical /Electronic Property Problem4
- Electromagnetic Interference3
- Over-Sensing3
- Mechanical Problem2
- Signal Artifact/Noise2
Patient problems
- Shock from Patient Lead(s)7
- Unspecified Infection6
- No Clinical Signs, Symptoms or Conditions4
- No Patient Involvement4
- No Known Impact Or Consequence To Patient3
- Bacteremia1
- Heart Failure/Congestive Heart Failure1
- Ventricular Fibrillation1
Recent adverse event reports
The 25 most recent of 25 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 10, 2025Signal Artifact/Noise; Electromagnetic Interference; Over-Sensing; Signal Artifact/Noise; Electromagnetic Interference; Over-Sensing
IT WAS REPORTED THAT THE RIGHT VENTRICULAR (RV) LEAD EXHIBITED STEADILY INCREASING PACING IMPEDANCE, AND TRENDS SHOWED A SIGNIFICANT JUMP IN IMPEDANCE VALUE FOLLOWED BY A NEW HIGH BASE LINE. IN ADDITION, THERE WERE HIGH RV CAPTURE THRESHOLDS. IT WAS FURTHER REPORTED THAT THE GRADUAL RISE IN IMPEDANCE AND THRESHOLDS WERE SUSPECTED TO BE RELATED TO POSSIBLE MINERALIZATION OF THE TIP ELECTRODE. IN ADDITION, ON THE DAY THAT THE PHYSICIAN WAS PLACING AN ATRIOVENTRICULAR FISTULA, THE RV LEAD TRIGGERED A LEAD INTEGRITY ALERT (LIA) FOR HIGH RATE NON-SUSTAINED EPISODES AND AN ELEVATED SENSING INTEGRITY COUNTER (SIC). OVERSENSING AND NOISE/ ELECTROMAGNETIC INTERFERENCE (EMI) WERE ALSO OBSERVED DURING THE PROCEDURE. THE LIA, OVERSENSING, AND NOISE/EMI WERE ALL ATTRIBUTED TO THE CAUTERY USED AT THE TIME. THE LEAD AND DEVICE REMAIN IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23769748 ↗InjuryOct 15, 2025Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem
IT WAS REPORTED VIA INTERNAL REVIEW OF HISTORICAL DATA TRANSMITTED FROM THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) THAT INAPPROPRIATE HIGH-VOLTAGE THERAPY WAS DELIVERED FOR SUPRA VENTRICULAR TACHYCARDIA (SVT) DETECTED IN THE VENTRICULAR TACHYCARDIA (VT) ZONE.
Patient problems: Shock from Patient Lead(s)
MAUDE report 23290039 ↗InjuryOct 15, 2025Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem
IT WAS REPORTED VIA INTERNAL REVIEW OF HISTORICAL DATA TRANSMITTED FROM THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) THAT INAPPROPRIATE HIGH-VOLTAGE THERAPIES WERE DELIVERED FOR ATRIAL FIBRILLATION (AF) WITH RAPID VENTRICULAR RESPONSE (RVR) DETECTED IN THE VENTRICULAR FIBRILLATION (VF) ZONE. THE DATA ALSO SHOWED FOLLOWING THE SECOND INAPPROPRIATE SHOCK, A TRUE VF ARRHYTHMIA WAS INDUCED AND WAS SUBSEQUENTLY TREATED WITH AN ADDITIONAL HIGH-VOLTAGE DEFIBRILLATION SHOCK. THE ICD REMAINS IN USE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Shock from Patient Lead(s); Ventricular Fibrillation
MAUDE report 23289447 ↗InjuryOct 15, 2025Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem
IT WAS REPORTED VIA INTERNAL REVIEW OF HISTORICAL DATA TRANSMITTED FROM THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) THAT INAPPROPRIATE HIGH-VOLTAGE THERAPY WAS DELIVERED FOR ATRIAL FIBRILLATION (AF) WITH RAPID VENTRICULAR RESPONSE (RVR) DETECTED IN THE VENTRICULAR TACHYCARDIA (VT) ZONE.
Patient problems: Shock from Patient Lead(s)
MAUDE report 23289442 ↗DeathMay 23, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS FURTHER REPORTED THAT THE PATIENT EXPIRED ONE WEEK POST-SYSTEM REMOVAL. FOLLOW-UP WITH THE PATIENT'S CLINIC WAS UNABLE TO CONFIRM A CAUSE OF DEATH. PER AN ONLINE OBITUARY, THE PATIENT EXPIRED DUE TO HEART FAILURE.
Patient problems: Heart Failure/Congestive Heart Failure; Unspecified Infection
MAUDE report 22078083 ↗MalfunctionJun 5, 2024Electromagnetic Interference; Over-Sensing; Electromagnetic Interference; Over-Sensing
IT WAS REPORTED THAT A STORED ATRIAL TACHYCARDIA/ATRIAL FIBRILLATION (AT/AF) EPISODE SHOWED ATRIAL OVERSENSING CONSISTENT WITH 60 HERTZ NOISE ON THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD). THE DEVICE REMAINS IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19468346 ↗InjuryFeb 29, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM WAS EXPLANTED DUE TO INFECTION. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Unspecified Infection
MAUDE report 18810103 ↗InjuryAug 30, 2023Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem
IT WAS REPORTED THAT THE PATIENT PRESENTED TO THE EMERGENCY DEPARTMENT DUE TO RECEIVING A SHOCK. A REMOTE MONITORING TRANSMISSION INDICATED THAT THE PATIENT WAS SHOCKED FOR A RHYTHM DETECTED IN THE VENTRICULAR TACHYCARDIA (VT) ZONE THAT WAS SUSPECTED TO BE SUPRA VENTRICULAR TACHYCARDIA (SVT). ADDITIONALLY, THE RIGHT VENTRICULAR (RV) LEAD OVERSENSED A BEAT AFTER A SHOCK WAS DELIVERED. THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND LEAD REMAIN IN USE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Shock from Patient Lead(s)
MAUDE report 17653406 ↗InjuryJun 16, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM WAS REMOVED DUE TO AN INFECTION. APPROXIMATELY THREE MONTHS LATER, A NEW ICD SYSTEM WAS IMPLANTED. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Unspecified Infection
MAUDE report 17142954 ↗InjuryMay 23, 2023Pacing Problem; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem; Pacing Problem; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem
IT WAS REPORTED, THAT THE PATIENT WAS INAPPROPRIATELY TREATED BY THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD), WITH ANTI-TACHYCARDIA PACING (ATP), AND SHOCK THERAPY. FOR DETECTING A SINUS TACHYCARDIA, AS A VENTRICULAR TACHYCARDIA (VT) EPISODE. THE DEVICE REMAINS IN USE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Shock from Patient Lead(s)
MAUDE report 16988857 ↗InjuryMay 19, 2023Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem
IT WAS REPORTED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DETECTED VENTRICULAR FIBRILLATION (VF) AND VENTRICULAR TACHYCARDIA (VT). THE DEVICE DELIVERED SHOCKS FOR BOTH. IT WAS SUSPECTED THAT THE RHYTHM FOR BOTH WAS ACTUALLY ATRIAL FIBRILLATION (AF) WITH RAPID VENTRICULAR RESPONSE (RVR), THEREFORE THE SHOCKS WERE INAPPROPRIATE. THE DEVICE REMAINS IN USE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Shock from Patient Lead(s)
MAUDE report 16962996 ↗InjuryMay 4, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM WAS EXTRACTED AND REPLACED DUE TO AN INFECTION. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Unspecified Infection
MAUDE report 16868801 ↗InjuryFeb 8, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PATIENT WAS HOSPITALIZED FOR AN INFECTION. BLOOD CULTURES TESTED POSITIVE AND WOUND CULTURES WERE NEGATIVE. THE PATIENT WAS TREATED WITH ANTIBIOTICS AND THE DEVICE SYSTEM WAS EXPLANTED. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Bacteremia
MAUDE report 16322398 ↗MalfunctionJan 17, 2023Failure to Capture; Failure to Capture
IT WAS REPORTED THAT THEY WERE UNABLE TO GET AN ELECTROCARDIOGRAM (EKG), IT IS BELIEVED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) IS FAILING TO CAPTURE. THE DEVICE REMAINS IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16184562 ↗MalfunctionMay 7, 2022Signal Artifact/Noise; Electromagnetic Interference; Over-Sensing; Signal Artifact/Noise; Electromagnetic Interference; Over-Sensing
IT WAS REPORTED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) TRIGGERED A LEAD INTEGRITY ALERT (LIA) FOR HIGH RATE NON-SUSTAINED EPISODES AND SENSING INTEGRITY COUNTER (SIC) DUE TO ELECTROMAGNETIC INTERFERENCE (EMI). THE EMI ALSO PRESENTED AS NOISE ON BOTH ATRIAL AND VENTRICULAR CHANNELS WITH NO EVIDENCE OF A LEAD ISSUE. THE DEVICE REMAINS IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14316984 ↗InjuryMar 19, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM WAS EXPLANTED DUE TO A INFECTION. CULTURES WERE TAKEN, AND THE PATIENT WAS TREATED WITH ANTIBIOTICS. A NEW SYSTEM WAS IMPLANTED AT A LATER DATE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Unspecified Infection
MAUDE report 9856612 ↗MalfunctionMar 18, 2020Electrical /Electronic Property Problem; Electrical /Electronic Property Problem
IT WAS REPORTED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DISPLAYED A GREY BAR FOR BATTERY LONGEVITY PRIOR TO IMPLANT. THE DEVICE WAS NEVER IMPLANTED. THERE WAS NO PATIENT INVOLVEMENT.
Patient problems: No Patient Involvement
MAUDE report 9850009 ↗MalfunctionMar 11, 2020Electrical /Electronic Property Problem; Electrical /Electronic Property Problem
IT WAS REPORTED THAT PRIOR TO IMPLANT, THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS INTERROGATED, AND THE LONGEVITY BAR WAS GRAY INSTEAD OF GREEN. THE ICD WAS NOT USED. NO PATIENT INVOLVEMENT.
Patient problems: No Patient Involvement
MAUDE report 9821914 ↗MalfunctionNov 11, 2019Mechanical Problem; Mechanical Problem
IT WAS REPORTED THAT DURING THE IMPLANT PROCEDURE, THE PHYSICIAN HAD PROBLEMS SECURING THE LEAD. THE SET SCREW WAS INDICATED TO HAVE BEEN BACKED OUT TOO MUCH. A DIFFERENT DEVICE WAS USED TO COMPLETE THE PROCEDURE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9305543 ↗InjuryOct 1, 2019Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem
IT WAS REPORTED THAT THE PATIENT RECEIVED INAPPROPRIATE THERAPY FOR ATRIAL FIBRILLATION (AF) WITH RAPID VENTRICULAR RESPONSE THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DETECTED AS VENTRICULAR FIBRILLATION (VF). THE ICD REMAINS IN USE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Shock from Patient Lead(s)
MAUDE report 9140859 ↗InjurySep 16, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED TWENTY-ONE DAYS POST GENERATOR CHANGE OUT THAT THE PATIENT APPEARED TO HAVE AN INFECTED DEVICE POCKET. THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM WAS EXPLANTED. THE PATIENT WAS PUT ON ANTIBIOTICS. IT WAS NOTED THAT THE PATIENT IS WEARING A LIFE VEST WHILE THEY HEAL. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Unspecified Infection
MAUDE report 9072268 ↗MalfunctionMar 27, 2019Electrical /Electronic Property Problem; Electrical /Electronic Property Problem
IT WAS REPORTED THAT PRIOR TO IMPLANT THE DEVICE DISPLAYED A "GRAY BAR" BATTERY LONGEVITY INDICATING A LOW TELEMETRY BATTERY VOLTAGE ISSUE. THE DEVICE WAS ATTEMPTED TO BE USED AGAIN AT A LATER DATE AND THE BATTERY HAD NOT RECOVERED. THE DEVICE WAS NOT UTILIZED AND NEVER IMPLANTED. THERE WAS NO PATIENT INVOLVEMENT IN THIS EVENT.
Patient problems: No Patient Involvement
MAUDE report 8458056 ↗MalfunctionMar 26, 2019Electrical /Electronic Property Problem; Electrical /Electronic Property Problem
IT WAS REPORTED THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) HAD GRAY BAR FOR LONGEVITY ESTIMATE. IT WAS NOTED THAT THE DEVICE WAS NEVER OPENED AND WAS NOT USED FOR ANY CASE. THEREFORE, THERE WAS NO PATIENT INVOLVEMENT.
Patient problems: No Patient Involvement
MAUDE report 8452996 ↗MalfunctionMar 21, 2019Mechanical Problem; Mechanical Problem
IT WAS REPORTED THAT DURING IMPLANT ATTEMPT, THE SETSCREW COULD NOT BE ENGAGED. THE DEVICE WAS NOT USED AND ANOTHER DEVICE WAS IMPLANTED. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8442357 ↗MalfunctionFeb 25, 2019Unable to Obtain Readings; Unable to Obtain Readings
IT WAS REPORTED THAT AFTER THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS IMPLANTED AND DURING INDUCTION TESTING POST-OPERATIVE A SCREEN DISPLAYED "NO INDUCTIONS PERFORMED DURING CURRENT SESSION" WHEN THE FIELD REPRESENTATIVE TRIED TO RETRIEVE DATA AFTER COMPLETING INDUCTION TESTING. IT WAS NOTED THE DEVICE DETECTED, AND SUCCESSFULLY TREATED DURING THE INDUCTION AND THE DEVICE FUNCTIONALITY WAS NORMAL. THE DEVICE REMAINS IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8368218 ↗
Other Implantable cardioverter defibrillator (non-CRT) devices
- EMBLEM™ MRI S-ICD A219Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)2 recalls36 deaths15,404 reports
- EMBLEM™ S-ICD A209Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)1 recall7 deaths6,788 reports
- EMBLEM™ S-ICD 3501Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)7 deaths4,936 reports
- Cobalt™ XT DR MRI SureScan™ DDPA2D4Medtronic, Inc. · Implantable cardioverter defibrillator (non-CRT)3 recalls30 deaths1,603 reports
- ENDOTAK RELIANCE® G 0185Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)9 deaths1,632 reports
- VIGILANT™ EL ICD DR D233Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)9 deaths1,563 reports
- Evera MRI™ XT DR SureScan® DDMB1D4Medtronic, Inc. · Implantable cardioverter defibrillator (non-CRT)1 recall35 deaths1,426 reports
- Durata™ 7122St. Jude Medical, Inc. · Implantable cardioverter defibrillator (non-CRT)27 deaths1,377 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page